Novel heart failure pharmacotherapy that targets nuclear signaling pathway in cardiac myocytes
Project/Area Number |
15K09108
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Cardiovascular medicine
|
Research Institution | Department of Clinical Research, National Hospital Organization Kyoto Medical Center |
Principal Investigator |
HASEGAWA Koji 独立行政法人国立病院機構(京都医療センター臨床研究センター), 展開医療研究部, 研究部長 (50283594)
|
Research Collaborator |
MORIMOTO Tatsuya 静岡県立大学
SUNAGAWA Yoichi 静岡県立大学
KATANASAKA Yasufumi 静岡県立大学
MIYAZAKI Yusuke 静岡県立大学
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 循環器・高血圧 / シグナル伝達 / 薬学 / トランスレーショナルリサーチ |
Outline of Final Research Achievements |
Heart failure is a leading cause of cardiovascular death. During development and deterioration of heart failure, cardiomyocytes undergo maladaptive hypertrophy, accompanied by re-induction of the fetal gene program. The transcriptional coactivator p300, an intrinsic histone acetyltransferase (HAT), is an important factor involved in the regulation of gene expression during cardiomyocyte hypertrophy. The natural compound, curcumin, possesses p300-specific HAT inhibitory activity. Our previous study demonstrated that curcumin prevents the development of cardiac hypertrophy by inhibiting p300-HAT activity. Here, we showed that demethoxycurcumin and bisdemethoxycurcumin, other major curcuminoids isolated from Curcuma longa, inhibited p300-HAT activity and cardiomyocyte hypertrophy to almost the same extent as curcumin. Thus, structural differences among the three compounds may not be involved in the inhibitory effects on p300-HAT activity and cardiac hypertrophy.
|
Report
(4 results)
Research Products
(16 results)
-
[Journal Article] MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.2016
Author(s)
Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, Nishino T, Hakuno D, Nakashima Y, Nishi H, Nakazeki F, Ide Y, Koyama S, Kimura M, Hanada R, Nakamura T, Inada T, Hasegawa K, Conway SJ, Kita T, Kimura T, Ono K.
-
Journal Title
Circ Res.
Volume: -
Issue: 5
Pages: 835-847
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD2016
Author(s)
Funamoto M, Sunagawa Y, Katanasaka Y, Miyazaki Y, Imaizumi A, Kakeya H, Yamakage H, Satoh-Asahara N, Komiyama M, Wada H, Hasegawa K, Morimoto T.
-
Journal Title
International Journal of Chronic Obstructive Pulmonary Disease
Volume: 11
Pages: 2029-2034
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Effect of Statins on Atherogenic Serum Amyloid A and α1-Antitrypsin Low-Density Lipoprotein Complexes2016
Author(s)
Miyazaki Y, Katanasaka Y, Sunagawa Y, Sae Hirano-Sunagawa, Funamoto M, Eriko Morimoto, Komiyama M, Shimatsu A, Satoh-Asahara N, Yamakage H, Wada H, Hasegawa K, Morimoto T.
-
Journal Title
International Journal of Cardiology
Volume: 3
Pages: 332-336
Related Report
Peer Reviewed / Open Access
-
-
-
[Presentation] Quitting Smoking Reduces Lectin-like low- density lipoprotein receptor-1 index, an Independent Cardiovascular Risk Marker of Vascular Inflammation2017
Author(s)
Maki Komiyama, Hiromichi Wada, Hajime Yamakage, Noriko Asahara, Sayaka Shimada, Masaharu Akao, Tatsuya Morimoto, Yuko Takahashi, Tatsuya Sawamura, Koji Hasegawa
Organizer
American Heart Association EPI/LIFESTYLE 2017
Related Report
Int'l Joint Research
-
-
[Presentation] Statins reduced atherogenic oxidatively modified low-density lipoprotein complexes: STAT-LVDF study2016
Author(s)
Yusuke Miyazaki, Yasufumi Katanasaka, Yoichi Sunagawa, Masafumi, Funamorto, Hidetoshi Suzuki, Hiromichi Wada, Noriko Asahara, Akira Shimatsu, Hajime Yamakage, Koji Hasegawa, and Tatsuya Morimoto
Organizer
International Society of Cardiomyopathies and Heart Failure Congress 2016
Place of Presentation
Kyoto
Related Report
Int'l Joint Research
-
[Presentation] Nobiletin, a polymethoxy flavonoid, prevents pressure-overload-induced systolic dysfunction in mice2016
Author(s)
Yoichi Sunagawa, Shintaro Ogawahara, Anna Suzuki, Masafumi Funamoto, Ryoga Sakurai, Yasufumi Katanasaka, Tomohiro Asakawa, Toshiyuki Kan, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto
Organizer
International Society of Cardiomyopathies and Heart Failure Congress 2016
Place of Presentation
Kyoto
Related Report
Int'l Joint Research
-
-
-
[Presentation] Analysis of Novel Target Molecules of Nobiletin, a Potent Therapeutic Agent Against Heart Failure2015
Author(s)
Yoichi Sunagawa, Kehima Hieda, Ryoga Sakurai, Shintaro Ogawahara, Yasufumi Katanasaka, Tomohiro Asakawa, Toshiyuki Kan, Akira Murakami, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto
Organizer
AHA Scientific Sessions 2015
Place of Presentation
Orlando, USA
Year and Date
2015-11-07
Related Report
Int'l Joint Research
-
-
-